Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Twist Bioscience Corporation - Common Stock
(NQ:
TWST
)
49.34
+1.43 (+2.98%)
Streaming Delayed Price
Updated: 1:13 PM EDT, Apr 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Twist Bioscience Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Biotech Beat Nvidia in 2025. Can It Do It Again?
↗
February 11, 2026
Big pharma and biotech take the earnings stage with reports from Eli Lilly and Novo Nordisk leading the lineup. Will they help the industry once again outperform AI champ Nvidia?
Via
The Motley Fool
Topics
Artificial Intelligence
Cold Chain, High Stakes: A Deep Dive into Azenta’s (AZTA) Life Sciences Transformation
February 05, 2026
Date: February 5, 2026 Introduction In the high-stakes world of life sciences, the "cold chain" is the invisible backbone of modern medicine. From the development of mRNA vaccines to the emerging...
Via
Finterra
Topics
Artificial Intelligence
Earnings
Economy
TWST Shares Rise 8% — What’s Driving The Rally?
↗
February 02, 2026
Twist Bioscience Corporation hiked its fiscal year 2026 revenue guidance on the heels of a first quarter earnings report that beat Wall Street estimates.
Via
Stocktwits
Topics
Artificial Intelligence
TWIST BIOSCIENCE CORP (NASDAQ:TWST) Reports Mixed Q1 FY2026 Results with Revenue Beat and Wider Loss
↗
February 02, 2026
Via
Chartmill
Earnings Scheduled For August 4, 2025
↗
August 04, 2025
Via
Benzinga
Preview: Twist Bioscience's Earnings
↗
August 01, 2025
Via
Benzinga
Earnings Scheduled For May 5, 2025
↗
May 05, 2025
Via
Benzinga
What's Next: Twist Bioscience's Earnings Preview
↗
May 02, 2025
Via
Benzinga
Twist Bioscience Q1 2026 Earnings Call Transcript
↗
February 02, 2026
Twist Bioscience Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses
↗
November 14, 2025
Twist Bioscience reports mixed Q4 earnings with a loss of 45 cents, sales of $99.01 million beating consensus.
Via
Benzinga
Twist Bioscience Corp (NASDAQ:TWST) Stock Falls After Q4 Earnings Miss
↗
November 14, 2025
Twist Bioscience Q4 2025 earnings miss analyst estimates on revenue and EPS, triggering a sharp pre-market stock decline.
Via
Chartmill
Topics
Earnings
Top Wall Street Forecasters Revamp Twist Bioscience Expectations Ahead Of Q4 Earnings
↗
November 14, 2025
Via
Benzinga
Earnings Outlook For Twist Bioscience
↗
November 13, 2025
Via
Benzinga
Earnings Scheduled For November 14, 2025
↗
November 14, 2025
Via
Benzinga
This Twist Bioscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
↗
November 04, 2025
Via
Benzinga
WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday
↗
October 20, 2025
Via
Benzinga
Topics
Artificial Intelligence
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns
↗
October 15, 2025
Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential.
Via
Benzinga
Topics
Artificial Intelligence
Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results
↗
August 05, 2025
Cathie Wood-led Ark Invest executed a significant trade in Block Inc. (NYSE:XYZ) on Tuesday.
Via
Benzinga
Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings
↗
August 04, 2025
Twist Bioscience beat Q3 revenue estimates, improved gross margins, and narrowed its full-year outlook while forecasting EBITDA breakeven fiscal 2026.
Via
Benzinga
Twist Bioscience (TWST) Q3 Profit Surges
↗
August 04, 2025
Via
The Motley Fool
Twist Bioscience Corp (NASDAQ:TWST) Reports Mixed Q3 2025 Results with Revenue Miss and EPS Beat
↗
August 04, 2025
Twist Bioscience reported mixed Q3 2025 results, missing revenue estimates at $96.06M but beating EPS at -$0.47. Shares fell 5% pre-market as investors focused on the sales shortfall.
Via
Chartmill
Cathie Wood's Ark Invest Continues To Offload Coinbase, Bets Big On SoFi Technologies
↗
June 27, 2025
Cathie Wood-led Ark Invest made notable trades on Friday, including selling shares in Coinbase and Roblox.
Via
Benzinga
Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit
↗
May 26, 2025
Cathie Wood underscored the application of AI in the healthcare sector by sharing new research by Mass General Brigham.
Via
Benzinga
Topics
Artificial Intelligence
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots
↗
May 12, 2025
Cathie Wood highlights the rising applications of AI and how it is poised to impact the health care space.
Via
Benzinga
Topics
Artificial Intelligence
Where Twist Bioscience Stands With Analysts
↗
May 06, 2025
Via
Benzinga
Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday
↗
May 06, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 02, 2025
Via
Benzinga
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
↗
March 01, 2025
Ark Invest made notable trades on Feb. 28, 2025. They purchased shares in ACHR, RXRX, TEM, and IRDM, while selling shares in TWST, ADYEY, ACCD, and EXAS.
Via
Benzinga
Topics
Artificial Intelligence
Cathie Wood's Ark Invest Loads Up On Iridium, Twist Bioscience, Offloads Roku: Here Are Key Ark Trades This Friday
↗
February 15, 2025
Cathie Wood-led Ark Invest made trades involving IRDM, TWST, PD, BEAM, ROKU, and IBTA.
Via
Benzinga
Cathie Wood Dumps $16 Million Worth Of Palantir Stock After Record Highs
↗
February 10, 2025
On Monday, February 10, 2025, the Cathie Wood-led Ark Invest sold nearly $16 million worth of Palantir shares amid a spike in the share price of the company.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
